跳至主要内容
临床试验/NCT01658085
NCT01658085Unknown不适用

Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease. A Randomized, Prospective Study

Hospital Universitari de Bellvitge1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
56
试验地点
1
主要终点
Operative time

研究概览

简要总结

Study Design Multinodular Goiter (MNG) patients requiring surgery were referred to the Endocrine Surgery Unit.

Indirect laryngoscopy was routinely performed preoperatively to assess normal motility in vocal folds (VF). Ultrasounds (US) study was performed the month previous to surgery to evaluate thyroid volume. Eligible patients met the following criteria: to have MNG, age between 18 and 80 and consent to be included in the study. Exclusion criteria included previous neck surgery, vocal fold impairment, permanent or transitory NSAID or analgesic treatment, coagulation disorders and any cognitive impairment.

Eligible patients were proposed to enter a randomized study with 2 arms in which we compared the use of two harmonic scalpel devices: ACE14S and Harmonic Focus (Ethicon Endo-Surgery, Cincinnati, OH, USA).

The main endpoint was operative time. Secondary endpoints were total and relative (%) time of use of the device along thyroidectomy, recurrent laryngeal nerve (RLN) injury and hypocalcaemia (both persistent or temporary), number of ligatures, length of skin incision, postoperative pain according to a visual scale of pain, QOL after thyroidectomy (EuroQOL) and budget impact analysis.

All patients were operated on by 2 surgeons, one senior (responsible for the Endocrine Surgery Unit) and one junior under supervision.

Randomization Randomization was performed the same day of surgery at the OR by using a closed envelope. Patients were randomized to Group I (ACE14S) or Group II (HF) and allocated in a 1:1 proportion; they reminded blinded until the end of the study about the device used.

The haemostasis device was communicated to the surgeon previous to start surgery. Medical staff of the Endocrine Surgery Unit collected clinical data.

Surgical Technique Total thyroidectomy (TT), defined as total bilateral extracapsular lobectomy 9, was performed using HF or ACE14S for vessel division. Monopolar and bipolar forceps for cutting and coagulation were routinely used. Ties were used under surgeon's criteria according to size of the vessels and/or the need to obtain haemostasis in the vicinity of the RLN when bipolar forceps were not considered safe enough.

详细描述

OBJECTIVE:

To disclose the potential advantages and outcomes of the new Harmonic Focus (HF) device compared to Harmonic Scalpel ACE14S (ACE-14S) in benign thyroid surgery.

STUDY DESIGN:

Controlled randomized study.

METHODS:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Multinodular goiter (MNG), age between 18 and 80 and consent to be included in the study

排除标准

  • previous neck surgery
  • vocal fold impairment
  • permanent or transitory NSAID or analgesic treatment,
  • coagulation disorders
  • any cognitive impairment.

结局指标

主要结局

Operative time

时间窗: Surgical time from skin incision to closure (about 70 minutes)

Operative time was measured from skin incision to removal of thyroid gland. The percentage of time using the device along TT was calculated as follows: time of use of the device x 100/ operative time.

次要结局

  • Total and relative (%) time of use of the device along thyroidectomy(From skin incision to removal of thyroid gland (about 30 minutes))
  • Recurrent laryngeal nerve (RLN) injury(From surgery to 6 months)
  • hypocalcemia (both persistent or temporary)(Daily, from surgery to discharge (24h), or up to 6 months)
  • postoperative pain according to a visual scale of pain(From surgery to 7 days)
  • QOL after thyroidectomy (EuroQOL)(1st and 7th postoperative day)
  • Number of ligatures(Day of surgery)
  • Length of skin incision(Day of surgery)
  • budget impact analysis(From surgery to discharge (24h))

研究者

发起方
Hospital Universitari de Bellvitge
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pablo Moreno Llorente

Chief endocrine Surgery Unit

Hospital Universitari de Bellvitge

研究点 (1)

Loading locations...

相似试验